From: Therapeutic potential of heterocyclic pyrimidine scaffolds
Compound | Human cancer cell lines | ||
---|---|---|---|
Origin | Designation | 48 h-MTT GI50 (µM) ± SD | |
b1 | Colon carcinoma | HCT-116 | 0.79 ± 0.08 |
Breast carcinoma | MCF-7 | 0.64 ± 0.08 | |
 | MDA-MB468 | 1.51 ± 0.34 | |
Lung carcinoma | A549 | 2.01 ± 0.55 | |
Ovarian carcinoma | A2780 | 1.00 ± 0.11 | |
Cervical carcinoma | HeLa | 0.90 ± 0.07 | |
Pancreatic carcinoma | Miacapa-2 | 1.25 ± 0.26 |